CVE-2026-52866
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Missing Authorization
Using Blood Glucose Monitoring System (Model No. APG-01 BT) by Apollo Pharmacy?
Get instant alerts when new vulnerabilities affect Blood Glucose Monitoring System (Model No. APG-01 BT) - before attackers find them.
Description
An attacker within BLE communication range can monopolize the device's only available BLE connection slot, preventing legitimate users or applications from establishing a connection.
Affected
Our own answer: ranges merged, affected separated from platform-only, with confidence and review flags.
Remediation
No guide yetNo remediation guidance has been written for this CVE yet, and no fixed version or vendor advisory is recorded against it.
References (4)
SSVC — Action Prioritization
SSVC signals action urgency (what to patch first), separate from CVSS which measures severity.
CVSS
- Attack Vector
- ADJACENT_NETWORK
- Complexity
- LOW
- Privileges
- NONE
- User Interaction
- NONE
- Scope
- UNCHANGED
- Confidentiality
- NONE
- Integrity
- NONE
- Availability
- HIGH
Quick Info
Get alerted
Stop reading CVE feeds looking for your own stack
Track the products you run and VulnTracker tells you when a new CVE affects them — with what is known about fixing it, and nothing about the rest.